Neuren Names Zita Peach Chair as Patrick Davies Steps Down
NEU: $23.66 -1.25% · MC: $2.9B
Neuren Pharmaceuticals has appointed Zita Peach as Board Chair, succeeding Patrick Davies, who has held the role since 2020. Peach brings more than 35 years of healthcare leadership, including experience in licensing, acquisitions and commercialisation; her initial director notice reports no relevant share interests, while Davies’ final notice records an indirect interest in Neuren shares.

Comments